Optimizing respiratory management in preterm infants : a review of adjuvant pharmacotherapies
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc..
Adjuvant respiratory therapies in preterm neonates aim to reduce long-term morbidities and mortality. Commonly utilized therapies include caffeine, systemic glucocorticosteroids, inhaled steroids, inhaled bronchodilators, and diuretics. This review discusses the available literature that supports some of these practices and points out where clinical practices are not corroborated by evidence. Therapies with no proven clinical benefit must be weighed against potential adverse effects.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Journal of perinatology : official journal of the California Perinatal Association - 41(2021), 10 vom: 09. Okt., Seite 2395-2407 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Koo, Jenny K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 21.10.2021 Date Revised 05.02.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41372-021-01139-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327904836 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327904836 | ||
| 003 | DE-627 | ||
| 005 | 20231225201819.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41372-021-01139-x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1092.xml |
| 035 | |a (DE-627)NLM327904836 | ||
| 035 | |a (NLM)34244615 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Koo, Jenny K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Optimizing respiratory management in preterm infants |b a review of adjuvant pharmacotherapies |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.10.2021 | ||
| 500 | |a Date Revised 05.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s), under exclusive licence to Springer Nature America, Inc. | ||
| 520 | |a Adjuvant respiratory therapies in preterm neonates aim to reduce long-term morbidities and mortality. Commonly utilized therapies include caffeine, systemic glucocorticosteroids, inhaled steroids, inhaled bronchodilators, and diuretics. This review discusses the available literature that supports some of these practices and points out where clinical practices are not corroborated by evidence. Therapies with no proven clinical benefit must be weighed against potential adverse effects | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Steinhorn, Robin |e verfasserin |4 aut | |
| 700 | 1 | |a C Katheria, Anup |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of perinatology : official journal of the California Perinatal Association |d 1993 |g 41(2021), 10 vom: 09. Okt., Seite 2395-2407 |w (DE-627)NLM01262943X |x 1476-5543 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2021 |g number:10 |g day:09 |g month:10 |g pages:2395-2407 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41372-021-01139-x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2021 |e 10 |b 09 |c 10 |h 2395-2407 | ||